Clinical trial
A Study to Compare the Safety and Effectiveness of Indinavir Combined With…
NCT00002424 · Merck Sharp & Dohme LLC, Industry · Suspended
Key facts
| NCT number | NCT00002424 |
|---|---|
| Title | A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine |
| Official title | A Multicenter, Double-Blind, Randomized Pilot Study to Compare the Safety and Activity of L-756423/Indinavir, 1600/800 Mg Qd or 800/400 Mg Bid Versus Indinavir, 800 Mg q8h, All in Combination With Stavudine and Lamivudine |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Suspended |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | L-756423, Indinavir sulfate, Lamivudine, Stavudine |
| Enrollment | 186 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: